Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GE Healthcare Completes Xcellerex Acquisition | Contract Pharma

What are you searching for?

Sign in
Breaking News

GE Healthcare Completes Xcellerex Acquisition

Expands biomanufacturing services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GE Healthcare has completed the acquisition of Xcellerex, Inc., expanding its offering of technologies and services for the manufacture of biopharmaceuticals such as recombinant proteins, antibodies and vaccines.
 
Dr. Nigel Darby, vice president of BioTechnologies, and chief technology officer, GE Healthcare Life Sciences said, “Xcellerex’s expertise and reputation in technologies for biopharmaceutical manufacturing is a great fit with our business. GE and Xcellerex share a vision that an integrated approach, where we can help customers optimize every stage of their manufacturing process – from start to finish – has the potential to increase production flexibility and to deliver higher yields of finished product while reducing time to market. We believe that combining the skills of the two companies will bring great benefits for our customers in the industry.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics